1. Home
  2. AHMA vs VERU Comparison

AHMA vs VERU Comparison

Compare AHMA & VERU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

AHMA

Ambitions Enterprise Management Co. L.L.C Class A Ordinary Shares

HOLD

Current Price

$1.37

Market Cap

49.3M

ML Signal

HOLD

Logo Veru Inc.

VERU

Veru Inc.

HOLD

Current Price

$2.80

Market Cap

45.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AHMA
VERU
Founded
2007
1971
Country
United Arab Emirates
United States
Employees
N/A
N/A
Industry
Services-Misc. Amusement & Recreation
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
49.3M
45.0M
IPO Year
2024
1996

Fundamental Metrics

Financial Performance
Metric
AHMA
VERU
Price
$1.37
$2.80
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$22.50
AVG Volume (30 Days)
34.3K
243.9K
Earning Date
05-22-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$16,296,958.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$180.72
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.76
$2.05
52 Week High
$39.50
$7.33

Technical Indicators

Market Signals
Indicator
AHMA
VERU
Relative Strength Index (RSI) 39.12 58.18
Support Level $1.03 $2.12
Resistance Level $1.88 $2.87
Average True Range (ATR) 0.10 0.13
MACD -0.01 0.02
Stochastic Oscillator 21.43 86.12

Price Performance

Historical Comparison
AHMA
VERU

About AHMA Ambitions Enterprise Management Co. L.L.C Class A Ordinary Shares

Ambitions Enterprise Management Co LLC, through its subsidiaries in the UAE, operates as a tour operator, travel agency, and event planning and management services provider. It provides two lines of services, namely, MICE management, a comprehensive coordination and organization of events, and one-stop tourism, a comprehensive travel product that is designed to provide tourists with all the necessary components of a trip in a single and convenient package, which typically include transportation, accommodations, meals, and guided tours or activities.

About VERU Veru Inc.

Veru Inc is a late clinical-stage biopharmaceutical focused on developing medicines for the treatment of cardiometabolic and inflammatory diseases. Its drug development program consists of two late-stage new chemical entities, enobosarm and sabizabulin. Enobosarm, an oral selective androgen receptor modulator, is being developed to make weight reduction by GLP-1 RA drugs more tissue selective for loss of fat and preservation of lean mass, and is planned for a Phase 2b PLATEAU clinical study in obesity. Sabizabulin, an oral microtubule disruptor, is being developed for the treatment of inflammation in atherosclerotic cardiovascular disease to lower high-sensitivity CRP in patients with stable coronary artery disease, with a planned Phase 2 study.

Share on Social Networks: